This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Teijin Pharma Limited. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Takuya Nanjo: Innovator in Phototherapy Technologies
Introduction
Takuya Nanjo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of phototherapy, particularly in the treatment of irritable bowel syndrome. With a total of 4 patents to his name, Nanjo continues to push the boundaries of medical technology.
Latest Patents
One of his latest inventions is a light beam irradiation apparatus designed to provide new treatment options for irritable bowel syndrome. This innovative device allows for percutaneous irradiation toward the sacral foramina, targeting one or both sides to alleviate symptoms. Another notable patent is a phototherapy device that includes a laser light source for emitting laser light at a target area. This device is equipped with a limit switch to detect proximity to the target and optical sensors to measure distance, ensuring precise treatment.
Career Highlights
Takuya Nanjo is currently employed at Teijin Pharma Limited, where he applies his expertise in developing advanced medical devices. His work focuses on enhancing the effectiveness of phototherapy treatments, making significant strides in patient care.
Collaborations
Nanjo collaborates with talented colleagues, including Naoya Ishibashi and Yuki Kawase, to further innovate in the field of medical technology. Their combined efforts contribute to the development of cutting-edge solutions for various health issues.
Conclusion
Takuya Nanjo is a dedicated inventor whose work in phototherapy is paving the way for new treatment options. His innovative patents reflect his commitment to improving patient outcomes and advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile